ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability
Authors:
- Lingjun WangLWLingjun Wang
- Bo ChenBCBo Chen
- Qiang LiQLQiang Li
- Jiping WangJWJiping Wang
- Ming ZhaoMZMing Zhao
- Wei WuWWWei Wu
- Ping ZhuPZPing Zhu
- Xuliang HuangXHXuliang Huang
- Qiaobing HuangQHQiaobing Huang
- 1 July 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 297 (1) , H238-H246
Abstract
Advanced glycation end products (AGEs) accumulated in different pathological conditions have the potent capacity to alter cellular properties that include endothelial structural and functional regulations. The disruption of endothelial barrier integrity may contribute to AGE-induced microangiopathy and macrovasculopathy. Previous studies have shown that AGEs induced the rearrangement of actin and subsequent hyperpermeability in endothelial cells (ECs). However, the mechanisms involved in this AGE-evoked EC malfunction are not well understood. This study directly evaluated the involvement of moesin phosphorylation in AGE-induced alterations and the effects of the RhoA and p38 MAPK pathways on this process. Using immortalized human dermal microvascular ECs (HMVECs), we first confirmed that the ezrin/radixin/moesin (ERM) protein moesin is required in AGE-induced F-actin rearrangement and hyperpermeability responses in ECs by knockdown of moesin protein expression with small interfering RNA. We then detected AGE-induced moesin phosphorylation by Western blot analysis. The mechanisms involved in moesin phosphorylation were analyzed by blocking AGE receptor binding and inhibiting Rho and MAPK pathways. AGE-treated HMVECs exhibited time- and dose-dependent increases in the Thr558 phosphorylation of moesin. The increased moesin phosphorylation was attenuated by preadministrations of AGE receptor antibody, Rho kinase (ROCK), or p38 inhibitor. Suppression of p38 activation via the expression of dominant negative mutants with Ad.MKK6b or Ad.p38α also decreased moesin phosphorylation. The activation of the p38 pathway by transfection of HMVECs with an adenoviral construct of dominant active MKK6b resulted in moesin phosphorylation. These results suggest a critical role of moesin phosphorylation in AGE-induced EC functional and morphological regulations. Activation of the ROCK and p38 pathways is required in moesin phosphorylation.Keywords
This publication has 37 references indexed in Scilit:
- Selectivity of Docking Sites in MAPK KinasesJournal of Biological Chemistry, 2009
- Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrierAmerican Journal of Physiology-Cell Physiology, 2008
- AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cellsAmerican Journal of Physiology-Renal Physiology, 2008
- Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic DysfunctionJournal of Neuroscience, 2008
- Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathyExperimental & Molecular Medicine, 2008
- ERM proteins in epithelial cell organization and functionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetesDiabetologia, 2006
- Phosphorylation of ezrin enhances microvillus length via a p38 MAP-kinase pathway in an immortalized mouse hepatic cell lineExperimental Cell Research, 2006
- Akt2 Phosphorylates Ezrin to Trigger NHE3 Translocation and ActivationJournal of Biological Chemistry, 2005